ADAM10 and hepatocellular carcinoma: Exosomes from miR-122-modified adipose-derived mesenchymal stem cells (AMSCs) can inhibit the expression of ADAM10, IGF1R, and CCNG1, thereby increasing the chemosensitivity of HCC cells to sorafenib [72].